TY - JOUR
T1 - Multi-center, international endometrial cancer consortium highlights
AU - De Vitis, Luigi
AU - Giudici, Anna
AU - Tarantino, Vincenzo
AU - Ostby, Stuart
AU - Bruce, Kelly
AU - Breitkopf, Daniel
AU - Olawaiye, Alexander
AU - Eskander, Ramez N.
AU - Coleman, Robert L.
AU - Momeni-Boroujeni, Amir
AU - Deavers, Michael
AU - Shahi, Maryam
AU - Scambia, Giovanni
AU - Dinoi, Giorgia
AU - Powell, Matthew
AU - Weroha, John
AU - Ellenson, Lora H.
AU - Zand, Behrouz
AU - Kumar, Amanika
AU - Gorzelitz, Jessica
AU - Mueller, Jennifer
AU - Nogueira-Rodrigues, Angelica
AU - Leitao, Mario M.
AU - Kilowski, Karolina
AU - Garda, Allison
AU - Alektiar, Kaled
AU - Reynolds, Evelyn
AU - Wahner Hendrickson, Andrea E.
AU - Mutch, David
AU - Abu-Rustum, Nadeem R.
AU - Ramirez, Pedro T.
AU - Mariani, Andrea
AU - Glaser, Gretchen E.
N1 - Publisher Copyright:
© 2025 European Society of Gynaecological Oncology and the International Gynecologic Cancer Society
PY - 2025/5
Y1 - 2025/5
N2 - The multi-center, international consortium on endometrial cancer held in January 2025 at Mayo Clinic in Rochester, Minnesota brought together leading experts in gynecologic oncology to explore the latest advancements in the understanding, diagnosis, and treatment of endometrial cancer. Discussions centered on key topics, including updates in molecular testing and disease staging, emerging treatment strategies for advanced and recurrent disease, fertility-sparing management, and critical pathology challenges, particularly, the assessment of lympho-vascular space invasion. Each topic was examined in dedicated working group sessions, fostering in-depth exchanges to identify research priorities and develop actionable strategies. This summary highlights the central themes and insights from the meeting, outlining a roadmap for future advancements in the field. By promoting inter-disciplinary collaboration, the meeting laid the foundation for future research, policy recommendations, and clinical innovations aimed at improving patient outcomes.
AB - The multi-center, international consortium on endometrial cancer held in January 2025 at Mayo Clinic in Rochester, Minnesota brought together leading experts in gynecologic oncology to explore the latest advancements in the understanding, diagnosis, and treatment of endometrial cancer. Discussions centered on key topics, including updates in molecular testing and disease staging, emerging treatment strategies for advanced and recurrent disease, fertility-sparing management, and critical pathology challenges, particularly, the assessment of lympho-vascular space invasion. Each topic was examined in dedicated working group sessions, fostering in-depth exchanges to identify research priorities and develop actionable strategies. This summary highlights the central themes and insights from the meeting, outlining a roadmap for future advancements in the field. By promoting inter-disciplinary collaboration, the meeting laid the foundation for future research, policy recommendations, and clinical innovations aimed at improving patient outcomes.
KW - Disease Staging
KW - Endometrial Cancer
KW - Fertility-Sparing Treatments
KW - Lympho-vascular Space Invasion
KW - Novel Therapies
UR - http://www.scopus.com/inward/record.url?scp=105002815324&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=105002815324&partnerID=8YFLogxK
U2 - 10.1016/j.ijgc.2025.101805
DO - 10.1016/j.ijgc.2025.101805
M3 - Editorial
C2 - 40252598
AN - SCOPUS:105002815324
SN - 1048-891X
VL - 35
JO - International Journal of Gynecological Cancer
JF - International Journal of Gynecological Cancer
IS - 5
M1 - 101805
ER -